Nanodetex Corporation v. Defiant Technologies

349 F. App'x 312
CourtCourt of Appeals for the Tenth Circuit
DecidedOctober 15, 2009
Docket08-2123
StatusUnpublished
Cited by7 cases

This text of 349 F. App'x 312 (Nanodetex Corporation v. Defiant Technologies) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nanodetex Corporation v. Defiant Technologies, 349 F. App'x 312 (10th Cir. 2009).

Opinion

ORDER AND JUDGMENT *

NEIL M. GORSUCH, Circuit Judge.

Defiant claims that Nanodetex maliciously abused legal process by filing a meritless lawsuit against it that was really aimed at “tying up” Defiant in litigation so that it could not pursue its business plan and would be forced to merge its business into Nanodetex’s. At trial, the jury agreed and awarded Defiant $2,000,001 in damages. Nanodetex now appeals this result. In this diversity dispute, all the matters on appeal before us concern the application of New Mexico state tort law, with Nanodetex arguing centrally that insufficient evidence exists to support the jury’s liability verdict and the damages it awarded. Our review of the evidence, however, reveals no such reversible error. The jury’s verdict, if not the only possible outcome, represented a reasonably available one in light of the evidence adduced at trial. Our standards of review and system of appeal afford substantial deference to facts found and damages awarded by the jury, and in this case they require us to affirm.

I

A

Sandia Corporation operates the government-owned Sandia National Laboratories for the United States Department of Energy. Sandia’s focus is national security, and its mandate includes developing and *315 licensing technology to private companies. One of Sandia’s patented devices is the MicroChemLab, a miniature chemical laboratory used to identify the presence of chemical and biological warfare agents even in very low concentrations. The device is designed for use in places such as subways and airports, where it might be deployed inconspicuously as a sort of early warning device against weapons of mass destruction.

In 2000, Alan Sylwester, Angelo Sala-mone, Patrick Lewis, and Ronald Mangi-nell, all Sandia employees, began the process of leaving Sandia and forming the company that later became Nanodetex, with plans to exploit the MicroChemLab’s commercial potential. This development was perfectly normal at Sandia, which even has a program to encourage such collaborative spin-off ventures. In due course, Nanodetex and Sandia entered into a licensing agreement that allowed Nano-detex to market Sandia’s MicroChemLab to commercial (nongovernmental) entities.

Soon, though, Nanodetex’s founders began quarreling, and Mr. Lewis and Mr. Manginell returned to Sandia, where they resumed working in the division responsible for the MicroChemLab technology. Whether because of this or other developments, the relationship between Sandia and Nanodetex also began to sour about this time. Sandia contended that Nanode-tex failed to meet financing requirements and performance milestones required by the parties’ licensing agreement. Nanode-tex responded in kind, claiming that it was really Sandia who had breached the parties’ agreement, and, in furtherance of this claim, Nanodetex filed a $225 million lawsuit against Sandia in federal district court.

It is here where the events giving rise to our ease really begin in earnest. After Nanodetex announced its lawsuit at a press conference, a reporter attending the event asked Mr. Sylwester and Mr. Sala-mone whether the license rights at issue in Nanodetex’s lawsuit were the same rights that a newly-created company, Defiant Technologies, recently acquired from San-dia. The news of Defiant’s existence and potential relationship with Sandia was surprising news to Nanodetex. Following this conversion, Mr. Sylwester examined Defiant’s website, which seemed to suggest that Defiant indeed had some relationship with Sandia involving MicroChemLab technology. The website identified Mr. Lewis and Mr. Manginell as two of Defiant’s founders and made the following claims: “Defiant uses field-proven technology developed at Sandia National Laboratories by the founders”; “Defiant’s technology is well proven. We have operated our system continuously for two years in a busy subway without a single false alarm”; and “Defiant’s technology was developed by the founders over the course of the past 9 years.... The founders of Defiant not only invented much of this technology while at Sandia National Labs, but they have spent the past five years improving the components for production and applying the technology in several fields.” App. 1353-54.

Later the same day, Allan Schwartz, a stakeholder in and former lawyer for Na-nodetex, called the phone number listed on Defiant’s website, which turned out to be the home number of Doug Adkins, one of Defiant’s principals. Mr. Schwartz asked Mr. Adkins if he had seen Nanodetex’s press conference earlier that day and then predicted that “Defiant would be pulled into this lawsuit that Nanodetex was filing against Sandia if [Adkins] didn’t roll [his] company into Nanodetex.” App. 1194. Mr. Schwartz suggested that they “could combine the companies and [Mr. Adkins] could take [his] Sandia license and roll it— *316 you know, the IP from that and roll it into the IP that was owned by Nanodetex.” Id. at 1195. Mr. Adkins declined the offer, stating that he “wasn’t interested in going into business with A1 [Sylwester] and Angelo [Salamone]” and that Defiant did not have a license with Sandia. Id. Mr. Schwartz agreed that Mr. Sylwester and Mr. Salamone were bad businessmen and said that “basically he was going to give them some money to go away.” Id. He also offered to invest $10 million in Defiant. Mr. Schwartz ended the call by reminding Mr. Adkins that litigation would keep Defiant’s technology “tied up for years.” Id. at 1194.

The following day, Mr. Sylwester and Mr. Salamone consulted Nanodetex’s litigation counsel, and Nanodetex’s board voted to include claims against Defiant in its preexisting lawsuit against Sandia. Soon thereafter, Nanodetex filed an amended complaint alleging that Defiant had tor-tiously interfered with its relationship with Sandia and converted Nanodetex’s property interest in its license with Sandia. The amended complaint also included conspiracy claims against Mr. Lewis, Mr. Adkins, and Mr. Manginell.

Defiant replied with various counterclaims against Nanodetex and its principals, Mr. Sylwester and Mr. Salamone. Among other things, Defiant alleged that Nanodetex’s suit against it constituted malicious abuse of process and tortious interference. Citing the conversation between Mr. Schwartz and Mr. Adkins, Defiant claimed that Nanodetex’s lawsuit amounted to an improper attempt to inhibit Defiant’s business opportunities and force Defiant to merge into Nanodetex. Among other things, Defiant noted that, contrary to the contentions in Nanodetex’s complaint, it had not secured any license with Sandia allowing it to exploit MicroChem-Lab technology commercially. Instead, Defiant had only sought to make sales of the technology to the federal government, something it was entirely free to do in light of the fact that Nanodetex’s license afforded it rights only to commercial sales, leaving others free to sell Sandia’s Micro-ChemLab technology to governmental entities.

B

Much motion practice and the usual last-minute settlement discussions ensued. By the time the district court finished with Nanodetex’s and Defiant’s competing summary judgment and judgment as a matter of law motions, the jury was left to decide only Defiant’s counterclaims for malicious abuse of process and tortious interference.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Francis v. Meyer
D. Kansas, 2022
Hansen v. Fields Company
763 S.E.2d 31 (Supreme Court of South Carolina, 2014)
Synthes, Inc. v. Emerge Medical, Inc.
25 F. Supp. 3d 617 (E.D. Pennsylvania, 2014)
Carolina Casualty Insurance v. Nanodetex Corporation
733 F.3d 1018 (Tenth Circuit, 2013)
Been v. O.K. Industries, Inc.
398 F. App'x 382 (Tenth Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
349 F. App'x 312, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nanodetex-corporation-v-defiant-technologies-ca10-2009.